Kentaro Tsuboi

Islet amyloid with macrophage migration correlates with augmented β-cell deficits in type 2 diabetic patients

S. Yagihashi, H. Mizukami, Wataru Inaba, 2014, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Effects of long-term treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin on islet endocrine cells in non-obese type 2 diabetic Goto-Kakizaki rats.

S. Yagihashi, H. Mizukami, Wataru Inaba, 2012, European journal of pharmacology.

The Effects of Dipeptidyl-Peptidase-IV Inhibitor, Vildagliptin, on the Exocrine Pancreas in Spontaneously Diabetic Goto-Kakizaki Rats

S. Yagihashi, H. Mizukami, Wataru Inaba, 2013, Pancreas.

The dipeptidyl peptidase IV inhibitor vildagliptin suppresses development of neuropathy in diabetic rodents: effects on peripheral sensory nerve function, structure and molecular changes

S. Yagihashi, H. Mizukami, M. Baba, 2016, Journal of neurochemistry.

Age‐associated changes of islet endocrine cells and the effects of body mass index in Japanese

S. Yagihashi, H. Mizukami, Wataru Inaba, 2013, Journal of diabetes investigation.

Involvement of Oxidative Stress–Induced DNA Damage, Endoplasmic Reticulum Stress, and Autophagy Deficits in the Decline of β-Cell Mass in Japanese Type 2 Diabetic Patients

S. Yagihashi, H. Mizukami, Wataru Inaba, 2014, Diabetes Care.